English 
CRISPR and Beyond: Japan’s Strategic Blueprint for the Future of Gene Editing
Gene editing is no longer a lab experiment sitting in the background. For Japan, it has become a pillar of economic competitiveness. Business leaders who still treat CRISPR as a niche science risk missing what is shaping up to be one of the most decisive growth engines of the next decade. CRISPR, the precise tool that can rewrite genetic code, is already transforming healthcare, food systems, and industrial manufacturing worldwide. In Japan, it is directly tied to national ambition. The government’s Bioeconomy Strategy sets a bold goal: to become the most advanced bioeconomy society by 2030. That is not just rhetoric. Japan has targeted an expansion of its bioeconomy market to ¥100 trillion by the end of the decade, anchoring biotech as a driver of future prosperity. This is not…
日本語